Lymphedema and subclinical lymphostasis (microlymphedema) facilitate cutaneous infection, inflammatory dermatoses, and neoplasia: A locus minoris resistentiae

Clinics in Dermatology

Volumn 32, Issue 5, 2014, Pages 599-615

  Carlson, J Andrew ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINIC ELASTOSIS; ADAPTIVE IMMUNITY; ANGIOSARCOMA; ANOGENITAL LOCALIZED LYMPHEDEMA; ANOGENITAL LYMPHEDEMATOUS FIBROEPITHELIAL POLYP; CELLULITIS; CHRONIC INFLAMMATION; CROHN DISEASE; CUTANEOUS WHIPPLE DISEASE; DERMATITIS; DERMATOCHALASIS; ELASTOSIS; ELEPHANTIASIS; EYELID DISEASE; GRANULOMATOUS LYMPHANGIITIS; HISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOLOGICAL TOLERANCE; INTESTINE LIPODYSTROPHY; INTRAVASCULAR HISTIOCYTOSIS; LABIAL MINORA HYPERTROPHY; LEPROSY; LOCUS MINORIS RESISTENTIAE; LYMPHANGIECTASIS; LYMPHANGIOGENESIS; LYMPHANGITIS; LYMPHATIC DRAINAGE; LYMPHEDEMA; MASTECTOMY; MICROLYMPHEDEMA; NON MELANOMA SKIN CANCER; NONHUMAN; NOTE; PAPILLOMAVIRUS INFECTION; PATHOGENESIS; POLYP; PRIORITY JOURNAL; ROSACEOUS LYMPHEDEMA; SKIN INFECTION; SKIN TUMOR; SUPERINFECTION; SUPPURATIVE HIDRADENITIS; ULTRAVIOLET RADIATION; VAGINA DISEASE; COMPLICATION; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; PATHOPHYSIOLOGY;

DERMATITIS; HUMANS; IMMUNOCOMPROMISED HOST; LYMPHEDEMA; SKIN DISEASES, INFECTIOUS; SKIN NEOPLASMS;

EID: 84906344525     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2014.04.007     Document Type: Note

References (126)

1. Dixon J.B. Lymphatic lipid transport: Sewer or subway? Trends in endocrinology and metabolism. Trends Endocrinol Metab 2010, 21:480-487.
2. Lu S., Tran T.A., Jones D.M., et al. Localized lymphedema (elephantiasis): A case series and review of the literature. J Cutan Pathol 2009, 36:1-20.
3. Paul J., Carlson J.A. Lymphangiectases are common underlying warts and in normal peritumoral skin: Histologic evidence of decreased immune surveillance. Am J Dermatopathol 2011, 33:152-160.
4. Paul J., Schaller J., Rohwedder A., et al. Treated Whipple disease with erythema nodosum leprosum-like lesions: Cutaneous pas-positive macrophages slowly decrease with time and are associated with lymphangiectases: A case report. Am J Dermatopathol 2011, 32:362-370.
5. Carlson J.A., Schaller J., Sell S. Comment on: Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease. J Antimicrob Chemother 2011, 66:2681-2682.
6. Nagi K.S., Carlson J.A., Wladis E.J. Histologic assessment of dermatochalasis: Elastolysis and lymphostasis are fundamental and interrelated findings. Ophthalmology 2011, 118:1205-1210.
7. Carlson J.A., Carlson G.D., Murphy M., et al. Lichen sclerosus exhibiting histologic signs of lymphedema: An essential factor in the pathogenesis of verruciform xanthoma. Arch Dermatol 2012, 148:260-262.
8. Barrett M.M., Carlson J.A. A clinicopathologic study of labia minora hypertrophy: Signs of localized lymphedema were universal. J Low Genit Tract Dis 2014 Jan., 18(1):13-20. PubMed PMID: 23760147.
9. Ruocco V., Schwartz R.A., Ruocco E. Lymphedema: An immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol 2002, 47:124-127.
10. Ruocco E., Puca R.V., Brunetti G., et al. Lymphedematous areas: Privileged sites for tumors, infections, and immune disorders. Int J Dermatol 2007, 46:662.
11. Földi E., Földi M. Földi's Textbook of Lymphology 2006, Elsevier GmbH, Munich.
12. Alitalo K. The lymphatic vasculature in disease. Nat Med 2011, 17:1371-1380.
13. Rossy K. Lymphedema. Medscape Reference [serial on the Internet] 2013, [Available from: http://emedicine.medscape.com/article/1087313-overview].
14. Ridner S.H. Pathophysiology of lymphedema. Semin Oncol Nurs 2013, 29:4-11.
15. Harwood C.A., Mortimer P.S. Causes and clinical manifestations of lymphatic failure. Clin Dermatol 1995, 13:459-471.
16. International Society of Lymphology The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology 2013, 46:1-11.
17. McPherson T., Persaud S., Singh S., et al. Interdigital lesions and frequency of acute dermatolymphangioadenitis in lymphoedema in a filariasis-endemic area. Br J Dermatol 2006, 154:933-941.
18. Paskett E.D., Naughton M.J., McCoy T.P., et al. The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev 2007, 16:775-782.
19. Warren A.G., Brorson H., Borud L.J., et al. Lymphedema: A comprehensive review. Ann Plast Surg 2007, 59:464-472.
20. Beesley V., Janda M., Eakin E., et al. Lymphedema after gynecologic cancer treatment: Prevalence, correlates, and supportive care needs. Cancer 2007, 109:2607-2614.
21. Ryan M., Stainton M.C., Slaytor E.K., et al. Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer. Aust N Z J Obstet Gynaecol 2003, 43:148-151.
22. Stamatakos M., Stefanaki C., Kontzoglou K. Lymphedema and breast cancer: A review of the literature. Breast Cancer 2011, 18:174-180.
23. Mortimer P., Bates D.O., Brassington H.D., et al. The prevalence of arm oedema following treatment for breast cancer. Q J Med 1996, 89:377-380.
24. Paskett E.D., Dean J.A., Oliveri J.M., et al. Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: A review. J Clin Oncol 2012, 30:3726-3733.
25. Brewer M.B., Singh D.P. Massive localized lymphedema: Review of an emerging problem and report of a complex case in the mons pubis. Ann Plast Surg 2012, 68:101-104.
26. Schneider M., Conway E.M., Carmeliet P. Lymph makes you fat. Nat Genet 2005, 37:1023-1024.
27. Dean S.M., Zirwas M.J., Horst A.V. Elephantiasis nostras verrucosa: An institutional analysis of 21 cases. J Am Acad Dermatol 2011, 64:1104-1110.
28. Ridner S.H., Deng J., Fu M.R., et al. Symptom burden and infection occurrence among individuals with extremity lymphedema. Lymphology 2012, 45:113-123.
29. International Society of Lymphology The diagnosis and treatment of peripheral lymphedema. 2009 Concensus Document of the International Society of Lymphology. Lymphology 2009, 42:51-60.
30. Connell F., Brice G., Jeffery S., et al. A new classification system for primary lymphatic dysplasias based on phenotype. Clin Genet 2010, 77:438-452.
31. Ruocco E., Brunetti G., Brancaccio G., et al. Phlebolymphedema: Disregarded cause of immunocompromised district. Clin Dermatol 2012, 30:541-543.
32. Miaskowski C., Dodd M., Paul S.M., et al. Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery. PLoS One 2013, 8(4):e60164. PubMed PMID: 23613720. Pubmed Central PMCID: 3629060.
33. Finegold D.N., Schacht V., Kimak M.A., et al. HGF and MET mutations in primary and secondary lymphedema. Lymphat Res Biol 2008, 6:65-68.
34. Rasmussen J.C., Tan I.C., Marshall M.V., et al. Human lymphatic architecture and dynamic transport imaged using near-infrared fluorescence. Trans Oncol 2010, 3:362-372.
35. Tabibiazar R., Cheung L., Han J., et al. Inflammatory Manifestations of Experimental Lymphatic Insufficiency. PLoS Med 2006 July 18, 3(7):e254. PubMed PMID: 16834456.
36. Zinkernagel R.M. Antiinfection immunity and autoimmunity. Ann N Y Acad Sci 2002, 958:3-6.
37. Liao S., Cheng G., Conner D.A., et al. Impaired lymphatic contraction associated with immunosuppression. Proc Natl Acad Sci U S A 2011, 108:18784-18789.
38. Mallon E., Powell S., Mortimer P., et al. Evidence for altered cell-mediated immunity in postmastectomy lymphoedema. Br J Dermatol 1997, 137:928-933.
39. Stark R., Dwyer E., De Forest M. Effect of surgical ablation of regional lymph nodes on survival of skin homografts. Ann N Y Acad Sci 1960, 87:140-148.
40. Lambert P.B., Frank H.A., Bellman S., et al. The role of the lymph trunks in the response to allogeneic skin transplants. Transplantation 1965, 3:62-73.
41. Yin N., Zhang N., Xu J., et al. Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival. Transplantation 2011, 92:25-30.
42. Skobe M., Dana R. Blocking the path of lymphatic vessels. Nat Med 2009, 15:993-994.
43. Bordea C., Wojnarowska F., Morris P.J. Multiple cutaneous malignancies arising in limbs with signs of lymphatic insufficiency in transplant patients. Br J Plast Surg 1999, 52:619-622.
44. Rutkowski J.M., Moya M., Johannes J., et al. Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. Microvasc Res 2006, 72:161-171.
45. Petrek J.A., Senie R.T., Peters M., et al. Lymphedema in a cohort of breast carcinoma survivors 20years after diagnosis. Cancer 2001, 92:1368-1377.
46. Meeske K.A., Sullivan-Halley J., Smith A.W., et al. Risk factors for arm lymphedema following breast cancer diagnosis in black women and white women. Breast Cancer Res Treat 2009, 113:383-391.
47. Helyer L.K., Varnic M., Le L.W., et al. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Breast J 2010, 16:48-54.
48. Brorson H., Ohlin K., Olsson G., et al. Adipose tissue dominates chronic arm lymphedema following breast cancer: An analysis using volume rendered CT images. Lymphat Res Biol 2006, 4:199-210.
49. Lee S., Han J.S., Ross H.M., et al. Massive localized lymphedema of the male external genitalia: A clinicopathologic study of 6 cases. Hum Pathol 2013, 44:277-281.
50. Heller D.S., Fitzhugh V.A., Cracchiolo B., et al. Massive localized lymphedema of the vulva: Report of a case and review of the literature. J Low Genit Tract Dis 2014 April, 18(2):E46-E49. PubMed PMID: 24189310.
51. Chopra K., Tadisina K.K., Brewer M., et al. Massive localized lymphedema revisited: A quickly rising complication of the obesity epidemic. Ann Plast Surg 2013 May 30, PubMed PMID: 23722582.
52. Salas S., Stock N., Stoeckle E., et al. Chronic lymphedema due to morbid obesity: An exceptional cause of abdominal wall angiosarcoma. Virchows Arch 2008, 453:217-219.
53. Shon W., Ida C.M., Boland-Froemming J.M., et al. Cutaneous angiosarcoma arising in massive localized lymphedema of the morbidly obese: A report of five cases and review of the literature. Cutan Pathol 2011, 38:560-564.
54. Van Duyn J. Lymphedema in face scars. South Med J 1969, 62:1149-1150.
55. Van Duyn J. First appearance of lymphedema in facial scars. South Med J 1974, 67:1502-1503.
56. Warren A.G., Slavin S.A. Scar lymphedema: Fact or fiction?. Ann Plast Surg 2007, 59:41-45.
57. Good L.M., Francis S.O., High W.A. Scrotal elephantiasis secondary to hidradenitis suppurativa. J Am Acad Dermatol 2011, 64:993-994.
58. Baughman S.M., Cespedes R.D. Unusual presentation of hidradenitis suppurativa with massive enlargement of penis. Urology 2004, 64:377-378.
59. Fadare O., Brannan S.M., Arin-Silasi D., et al. Localized lymphedema of the vulva: A clinicopathologic study of 2 cases and a review of the literature. Int J Gynecol Pathol 2011, 30:306-313.
60. van der Zee H.H., Prens E.P., Boer J. Deroofing: A tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol 2010, 63:475-480.
61. Mortimer P.S., Cherry G.W., Jones R.L., et al. The importance of elastic fibres in skin lymphatics. Br J Dermatol 1983, 108:561-566.
62. Ryan T.J. Structure and function of lymphatics. J Invest Dermatol 1989, 93:18 S-24 S.
63. Gomaa A.H., Yaar M., Eyada M.M., et al. Lymphangiogenesis and angiogenesis in non-phymatous rosacea. J Cutan Pathol 2007, 34:748-753.
64. Aloi F., Tomasini C., Soro E., et al. The clinicopathologic spectrum of rhinophyma. J Am Acad Dermatol 2000, 42:468-472.
65. Carlson J.A., Mazza J., Kircher K., et al. Otophyma: A case report and review of the literature of lymphedema (elephantiasis) of the ear. Am J Dermatopathol 2008, 30:67-72.
66. Gallardo M.A., Bosch R.J., Vidal L., et al. Angiosarcoma arising on rhinophyma. Eur J Dermatol 2000, 10:555-558.
67. Acker D.W., Helwig E.B. Rhinophyma with carcinoma. Arch Dermatol 1967, 95:250-254.
68. Jansen T., Plewig G. Clinical and histologic variants of rhinophyma, including nonsurgical treatment modalities. Facial Plast Surg 1998, 14:241-253.
69. McKenna D.J., McKenna K. Basal cell carcinoma lurking within gross rhinophyma. Clin Exp Dermatol 2006, 31:173-174.
70. Rohrich R.J., Griffin J.R., Adams W.P. Rhinophyma: Review and update. Plast Reconstr Surg 2002, 110:860-869. [quiz 870].
71. Lutz M.E., Otley C.C. Rhinophyma and coexisting occult skin cancers. Dermatol Surg 2001, 27:201-202.
72. Motley R.J., Douglas-Jones A.F., Holt P.J. Sebaceous carcinoma: An unusual cause of a rapidly enlarging rhinophyma. Br J Dermatol 1991, 124:283-284.
73. Traaholt L., Eeg Larsen T. Rhinophyma and angiosarcoma of the nose. A case report. Scand J Plast Reconstr Surg 1978, 12:81-83.
74. Keefe M., Wakeel R.A., McBride D.I. Basal cell carcinoma mimicking rhinophyma. Case report and literature review. Arch Dermatol 1988, 124:1077-1079.
75. Ross D.A., Davies M.P. Squamous cell carcinoma arising in rhinophyma. J R Soc Med 1992, 85:236-237.
76. Kornblut A.D., Evers K. Rhinophyma and intranasal carcinoma. J Laryngol Otol 1973, 87:1137-1141.
77. Requena L., El-Shabrawi-Caelen L., Walsh S.N., et al. Intralymphatic histiocytosis. A clinicopathologic study of 16 cases. Am J Dermatopathol 2009, 31:140-151.
78. Saggar S., Lee B., Krivo J., et al. Intralymphatic histiocytosis associated with orthopedic implants. J Drugs Dermatol 2011, 10:1208-1209.
79. Washio K., Nakata K., Nakamura A., et al. Pressure bandage as an effective treatment for intralymphatic histiocytosis associated with rheumatoid arthritis. Dermatology 2011, 223:20-24.
80. Murphy M.J., Kogan B., Carlson J.A. Granulomatous lymphangitis of the scrotum and penis. Report of a case and review of the literature of genital swelling with sarcoidal granulomatous inflammation. J Cutan Pathol 2001, 28:419-424.
81. Van Kruiningen H.J., Colombel J.F. The forgotten role of lymphangitis in Crohn's disease. Gut 2008, 57:1-4.
82. van de Scheur M.R., van der Waal R.I., van der Waal I., et al. Ano-genital granulomatosis: The counterpart of oro-facial granulomatosis. J Eur Acad Dermatol Venereol 2003, 17:184-189.
83. Tonelli P. New development in Crohn's disease: Unravelling the mystery and its reinstatement as a surgically treatable condition. Part 2. Potential etiopathogenesis of "terminal ileitis" and extension of the disease to mesenteric small intestine and the colon. Chir Ital 2000, 52:243-250.
84. Mu X.C., Tran T.A., Dupree M., et al. Acquired vulvar lymphangioma mimicking genital warts. A case report and review of the literature. J Cutan Pathol 1999, 26:150-154.
85. Kaiserling E. Morphologic changes in lymphedema and tumors. Földi's Textbook of Lymphology 2006, 224-319. Elsevier GmbH, Munich. M. Földi, E. Földi (Eds.).
86. Uitto J. The role of elastin and collagen in cutaneous aging: Intrinsic aging versus photoexposure. J Drugs Dermatol 2008, 7:s12-s16.
87. Runger T.M. How different wavelengths of the ultraviolet spectrum contribute to skin carcinogenesis: The role of cellular damage responses. J Invest Dermatol 2007, 127:2103-2105.
88. Brozyna A., Zbytek B., Granese J., et al. Mechanism of UV-related carcinogenesis and its contribution to nevi/melanoma. Expert Rev Dermatol 2007, 2:451-469.
89. Slaughter D.P., Southwick H.W., Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953, 6:963-968.
90. Deltondo J.A., Helm K.F. Actinic keratosis: Precancer, squamous cell carcinoma, or marker of field cancerization?. G Ital Dermatol Venereol 2009, 144:441-444.
91. Kripke M.L. Ultraviolet radiation and immunology: Something new under the sun-presidential address. Cancer Res 1994, 54:6102-6105.
92. Slominski A. A nervous breakdown in the skin: Stress and the epidermal barrier. J Clin Invest 2007, 117:3166-3169.
93. Schwarz T. Ultraviolet radiation-induced tolerance. Allergy 1999, 54:1252-1261.
94. Schwarz A., Maeda A., Wild M.K., et al. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J Immunol 2004, 172:1036-1043.
95. Kajiya K., Kunstfeld R., Detmar M., et al. Reduction of lymphatic vessels in photodamaged human skin. J Dermatol Sci 2007, 47:241-243.
96. Pena J.M., Ford M.J. Cutaneous lymphangiectases associated with severe photoaging and topical corticosteroid application. J Cutan Pathol 1996, 23:175-181.
97. Back S.J., Kim Y.J., Choi D.K., et al. Cutaneous lymphangiectasia associated with photoageing and topical corticosteroid application. Clin Exp Dermatol 2009, 34:352-354.
98. Le Poole C., Denman C.J., Arbiser J.L. Immunosuppression may be present within condyloma acuminata. J Am Acad Dermatol 2008, 59:967-974.
99. Antonsson A., Karanfilovska S., Lindqvist P.G., et al. General acquisition of human papillomavirus infections of skin occurs in early infancy. J Clin Microbiol 2003, 41:2509-2514.
100. Antonsson A., Forslund O., Ekberg H., et al. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 2000, 74:11636-11641.
101. de Villiers E.M., Lavergne D., McLaren K., et al. Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer 1997, 73:356-361.
102. Antonsson A., Erfurt C., Hazard K., et al. Prevalence and type spectrum of human papillomaviruses in healthy skin samples collected in three continents. J Gen Virol 2003, 84:1881-1886.
103. Broker T.R., Jin G., Croom-Rivers A., et al. Viral latency-the papillomavirus model. Dev Biol (Basel) 2001, 106:443-451. [discussion 452-443, 465-475].
104. Mosovich B., Gatot A., Zirkin H. Widespread oral papillomatosis due to chronic buccal trauma. Cutis 1989, 43:254-257.
105. Keefe M., al-Ghamdi A., Coggon D., et al. Cutaneous warts in butchers. Br J Dermatol 1994, 130:9-14.
106. Roach M.C., Chretien J.H. Common hand warts in athletes: Association with trauma to the hand. J Am Coll Health 1995, 44:125-126.
107. French A., Masters E. Warts from minor trauma. Lancet 2002, 359:760.
108. Nai-Ming L., Yuk-Ming William T. Warts (non-genital). Clin Evid (Online) 2007, 2007. PubMed PMID: 19454080.
109. Schaller J., Carlson J.A. Erythema nodosum-like lesions in treated Whipple's disease: Signs of immune reconstitution inflammatory syndrome. J Am Acad Dermatol 2009, 60:277-288.
110. Kurata A., Terado Y., Izumi M., et al. Where does the antigen of cutaneous sarcoidosis come from?. J Cutan Pathol 2010, 37:211-221.
111. Choon S.E., Kang J., Neafie R.C., et al. Conidiobolomycosis in a young Malaysian woman showing chronic localized fibrosing leukocytoclastic vasculitis: A case report and meta-analysis focusing on clinicopathologic and therapeutic correlations with outcome. Am J Dermatopathol 2012, 34:511-522.
112. Lu S., Rohwedder A., Murphy M., et al. Verruciform xanthoma: Localized lymphedema (elephantiasis) is an essential pathogenic factor. J Cutan Pathol 2012, 39:391-394.
113. Carlson J.A., LeBoit P.E. Localized chronic fibrosing vasculitis of the skin: An inflammatory reaction that occurs in settings other than erythema elevatum diutinum and granuloma faciale. Am J Surg Pathol 1997, 21:698-705.
114. LeBoit P.E., Yen T.S., Wintroub B. The evolution of lesions in erythema elevatum diutinum. Am J Dermatopathol 1986, 8:392-402.
115. Lagier J.C., Fenollar F., Lepidi H., et al. Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease. J Antimicrob Chemother 2011, 66:1188-1189.
116. Scollard D.M., Adams L.B., Gillis T.P., et al. The continuing challenges of leprosy. Clin Microbiol Rev 2006, 19:338-381.
117. Carlson J.A., Dabiri G., Cribier B., et al. The immunopathobiology of syphilis: The manifestations and course of syphilis are determined by the level of delayed-type hypersensitivity. Am J Dermatopathol 2011, 33:433-460.
118. Ryan T.J., Jones R.L., Mortimer P.S., et al. Lymphatics in leprosy: Relationship to elastic fibres and observations following intra-lesional injections of colloidal carbon. Lepr Rev 2002, 73:52-63.
119. Lepidi H., Fenollar F., Gerolami R., et al. Whipple's disease: Immunospecific and quantitative immunohistochemical study of intestinal biopsy specimens. Hum Pathol 2003, 34:589-596.
120. Ryan T.J., Mallon E.C. Lymphatics and the processing of antigen. Clin Dermatol 1995, 13:485-492.
121. Moos V., Schneider T. Changing paradigms in Whipple's disease and infection with Tropheryma whipplei. Eur J Clin Microbiol Infect Dis 2011 Oct, 30(10):1151-1158. PubMed PMID:21461659.
122. Zinkernagel R.M., Hengartner H. On immunity against infections and vaccines: Credo 2004. Scand J Immunol 2004, 60:9-13.
123. Ackerman A.B., Chongchitnant N., Sanchez J.L., et al. Lymphedema. Histologic diagnosis of inflammatory skin diseases: An algorithmic method based on pattern analysis 1997, 826-828. Williams & Wilkins, Baltimore. 2nd ed.
124. Mortimer P. Disorders of lymphatic vessels. Rook/Wilkinson/Ebling Textbook of dermatology 1998, 2277-2296. Blackwell Science, Oxford, UK. H. Champion, J.L. Burton, D.A. Burns (Eds.).
125. Saito Y., Nakagami H., Kaneda Y., et al. Lymphedema and therapeutic lymphangiogenesis. Biomed Res Int 2013, 2013:804675. PubMed PMID: 24222916. Pubmed Central PMCID: 3810055.
126. Ruocco V., Brunetti G., Puca R.V., Ruocco E. The immunocompromised district: A unifying concept for limphoedematous, herpes-infected and otherwise damaged sites. J Eur Acad Dermatol Venereol 2009, 23:1364-1373.